Bardet-Biedl syndrome 1
diseaseOn this page
Also known as Bardet-Biedl syndrome 1, modifier ofBardet-Biedl syndrome type 1BBS1
Summary
Bardet-Biedl syndrome 1 (MONDO:0008854) is a disease caused by BBS1 (GenCC Definitive), with 18 cohort genes and 1 clinical trial. The dominant Reactome pathway is BBSome-mediated cargo-targeting to cilium (11 cohort genes).
At a glance
- Causal gene: BBS1 (GenCC Definitive)
- Cohort genes: 18
- ClinVar variants: 553
- Clinical trials: 1
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | Bardet-Biedl syndrome 1 |
| Mondo ID | MONDO:0008854 |
| MeSH | C537909 |
| OMIM | 209900 |
| DOID | DOID:0110123 |
| UMLS | C2936862 |
| MedGen | 422452 |
| GARD | 0000820 |
| Is cancer (heuristic) | no |
Also known as: Bardet-Biedl syndrome 1 · Bardet-Biedl syndrome 1, modifier of · Bardet-Biedl syndrome type 1 · BBS1
Data availability: 553 ClinVar variants · 7 GenCC gene-disease records.
Disease family
Classification path: disease › human disease › disease by body system or component › syndromic disease › Bardet-Biedl syndrome › Bardet-Biedl syndrome 1
Related subtypes (21): Bardet-Biedl syndrome 3, Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 4, Bardet-Biedl syndrome 5, Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 8, Bardet-Biedl syndrome 9, Bardet-Biedl syndrome 10, Bardet-Biedl syndrome 11, Bardet-Biedl syndrome 12, Bardet-Biedl syndrome 13, Bardet-Biedl syndrome 14, Bardet-Biedl syndrome 15, Bardet-Biedl syndrome 16, Bardet-Biedl syndrome 17, Bardet-Biedl syndrome 18, Bardet-Biedl syndrome 19, Bardet-Biedl syndrome 22, Bardet-Biedl syndrome 20, bardet-biedl syndrome 21
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
553 retrieved; paginated sample, class counts are floors:
225 uncertain significance, 77 likely pathogenic, 57 pathogenic, 55 pathogenic/likely pathogenic, 55 conflicting classifications of pathogenicity, 35 benign, 29 likely benign, 20 benign/likely benign
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 1075539 | NM_001278293.3(ARL6):c.4G>T (p.Gly2Ter) | ARL6 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 2041 | NM_001278293.3(ARL6):c.506G>C (p.Gly169Ala) | ARL6 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2042 | NM_001278293.3(ARL6):c.92C>T (p.Thr31Met) | ARL6 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 2044 | NM_001278293.3(ARL6):c.92C>G (p.Thr31Arg) | ARL6 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 438186 | NM_001278293.3(ARL6):c.281T>C (p.Ile94Thr) | ARL6 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 68064 | NM_001278293.3(ARL6):c.272T>C (p.Ile91Thr) | ARL6 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 126379 | NM_001195305.3(BBIP1):c.173T>G (p.Leu58Ter) | BBIP1 | Pathogenic | no assertion criteria provided |
| 1037244 | NM_024649.5(BBS1):c.1181-9C>G | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1074464 | NM_024649.5(BBS1):c.382C>T (p.Gln128Ter) | BBS1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1074693 | NM_024649.5(BBS1):c.1261C>T (p.Gln421Ter) | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1075093 | NM_024649.5(BBS1):c.830G>A (p.Arg277Lys) | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1076842 | NM_024649.5(BBS1):c.1657G>T (p.Glu553Ter) | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 12143 | NM_024649.5(BBS1):c.1169T>G (p.Met390Arg) | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 12144 | NM_024649.5(BBS1):c.1645G>T (p.Glu549Ter) | BBS1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 12145 | NM_024649.5(BBS1):c.432+1G>A | BBS1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 12146 | NM_024649.5(BBS1):c.851del (p.Tyr284fs) | BBS1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1299580 | NM_024649.5(BBS1):c.48-1G>A | BBS1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1324292 | NM_024649.5(BBS1):c.47+1G>T | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1373905 | NM_024649.5(BBS1):c.1385_1401dup (p.Leu468fs) | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1434855 | NM_024649.5(BBS1):c.1564del (p.Leu522fs) | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1457144 | NM_024649.5(BBS1):c.1A>G (p.Met1Val) | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1459324 | NM_024649.5(BBS1):c.607del (p.Thr202_Met203insTer) | BBS1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1504874 | NM_024649.5(BBS1):c.1708C>T (p.Arg570Ter) | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 188752 | NM_024649.5(BBS1):c.436C>T (p.Arg146Ter) | BBS1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 189103 | NM_024649.5(BBS1):c.1131_1135del (p.Cys377fs) | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 193740 | NM_024649.5(BBS1):c.887del (p.Ile296fs) | BBS1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1986958 | NM_024649.5(BBS1):c.2T>C (p.Met1Thr) | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2030272 | NM_024649.5(BBS1):c.1401C>G (p.Tyr467Ter) | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2057607 | NM_024649.5(BBS1):c.3G>A (p.Met1Ile) | BBS1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 2098720 | NM_024649.5(BBS1):c.723+2T>G | BBS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 8 · Orphanet: 24 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| BBS1 | Definitive | Autosomal recessive | Bardet-Biedl syndrome 1 | 7 |
| CCDC28B | No Known Disease Relationship | Autosomal recessive | Bardet-Biedl syndrome 1 |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| BBS1 | Orphanet:110 | Bardet-Biedl syndrome |
| BBS1 | Orphanet:791 | Retinitis pigmentosa |
| ARL6 | Orphanet:110 | Bardet-Biedl syndrome |
| ARL6 | Orphanet:791 | Retinitis pigmentosa |
| BBS7 | Orphanet:110 | Bardet-Biedl syndrome |
| BBS10 | Orphanet:110 | Bardet-Biedl syndrome |
| BBS12 | Orphanet:110 | Bardet-Biedl syndrome |
| WDPCP | Orphanet:110 | Bardet-Biedl syndrome |
| WDPCP | Orphanet:1338 | Heart defect-tongue hamartoma-polysyndactyly syndrome |
| BBIP1 | Orphanet:110 | Bardet-Biedl syndrome |
| BBS9 | Orphanet:110 | Bardet-Biedl syndrome |
| IFT172 | Orphanet:110 | Bardet-Biedl syndrome |
| IFT172 | Orphanet:140969 | Saldino-Mainzer syndrome |
| IFT172 | Orphanet:474 | Jeune syndrome |
| IFT172 | Orphanet:791 | Retinitis pigmentosa |
| LZTFL1 | Orphanet:110 | Bardet-Biedl syndrome |
| NPHP1 | Orphanet:110 | Bardet-Biedl syndrome |
| NPHP1 | Orphanet:220497 | Joubert syndrome with renal defect |
| NPHP1 | Orphanet:3156 | Senior-Loken syndrome |
| NPHP1 | Orphanet:93592 | Juvenile nephronophthisis |
| BBS2 | Orphanet:110 | Bardet-Biedl syndrome |
| BBS2 | Orphanet:791 | Retinitis pigmentosa |
| BBS4 | Orphanet:110 | Bardet-Biedl syndrome |
| BBS5 | Orphanet:110 | Bardet-Biedl syndrome |
Cohort genes → proteins
18 cohort genes, 18 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 18 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| CCDC28B | HGNC:28163 | ENSG00000160050 | Q9BUN5 | Coiled-coil domain-containing protein 28B | gencc,clinvar |
| BBS1 | HGNC:966 | ENSG00000174483 | Q8NFJ9 | BBSome complex member BBS1 | gencc,clinvar |
| ARL6 | HGNC:13210 | ENSG00000113966 | Q9H0F7 | ADP-ribosylation factor-like protein 6 | clinvar |
| BBS7 | HGNC:18758 | ENSG00000138686 | Q8IWZ6 | BBSome complex member BBS7 | clinvar |
| PSMG2 | HGNC:24929 | ENSG00000128789 | Q969U7 | Proteasome assembly chaperone 2 | clinvar |
| CEP76 | HGNC:25727 | ENSG00000101624 | Q8TAP6 | Centrosomal protein of 76 kDa | clinvar |
| BBS10 | HGNC:26291 | ENSG00000179941 | Q8TAM1 | BBSome complex assembly protein BBS10 | clinvar |
| BBS12 | HGNC:26648 | ENSG00000181004 | Q6ZW61 | Chaperonin-containing T-complex member BBS12 | clinvar |
| ZDHHC24 | HGNC:27387 | ENSG00000174165 | Q6UX98 | Probable palmitoyltransferase ZDHHC24 | clinvar |
| WDPCP | HGNC:28027 | ENSG00000143951 | O95876 | WD repeat-containing and planar cell polarity effector protein fritz homolog | clinvar |
| BBIP1 | HGNC:28093 | ENSG00000214413 | A8MTZ0 | BBSome-interacting protein 1 | clinvar |
| BBS9 | HGNC:30000 | ENSG00000122507 | Q3SYG4 | Protein PTHB1 | clinvar |
| IFT172 | HGNC:30391 | ENSG00000138002 | Q9UG01 | Intraflagellar transport protein 172 homolog | clinvar |
| LZTFL1 | HGNC:6741 | ENSG00000163818 | Q9NQ48 | Leucine zipper transcription factor-like protein 1 | clinvar |
| NPHP1 | HGNC:7905 | ENSG00000144061 | O15259 | Nephrocystin-1 | clinvar |
| BBS2 | HGNC:967 | ENSG00000125124 | Q9BXC9 | BBSome complex member BBS2 | clinvar |
| BBS4 | HGNC:969 | ENSG00000140463 | Q96RK4 | BBSome complex member BBS4 | clinvar |
| BBS5 | HGNC:970 | ENSG00000163093 | Q8N3I7 | BBSome complex member BBS5 | clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| CCDC28B | Coiled-coil domain-containing protein 28B | Involved in ciliogenesis. |
| BBS1 | BBSome complex member BBS1 | The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. |
| ARL6 | ADP-ribosylation factor-like protein 6 | Involved in membrane protein trafficking at the base of the ciliary organelle. |
| BBS7 | BBSome complex member BBS7 | The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. |
| PSMG2 | Proteasome assembly chaperone 2 | Chaperone protein which promotes assembly of the 20S proteasome as part of a heterodimer with PSMG1. |
| CEP76 | Centrosomal protein of 76 kDa | Centrosomal protein involved in regulation of centriole duplication. |
| BBS10 | BBSome complex assembly protein BBS10 | Probable molecular chaperone that assists the folding of proteins upon ATP hydrolysis. |
| BBS12 | Chaperonin-containing T-complex member BBS12 | Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis. |
| ZDHHC24 | Probable palmitoyltransferase ZDHHC24 | Probable palmitoyltransferase that could catalyze the addition of palmitate onto various protein substrates. |
| WDPCP | WD repeat-containing and planar cell polarity effector protein fritz homolog | Probable effector of the planar cell polarity signaling pathway which regulates the septin cytoskeleton in both ciliogenesis and collective cell movements. |
| BBIP1 | BBSome-interacting protein 1 | The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. |
| BBS9 | Protein PTHB1 | The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. |
| IFT172 | Intraflagellar transport protein 172 homolog | Required for the maintenance and formation of cilia. |
| LZTFL1 | Leucine zipper transcription factor-like protein 1 | Regulates ciliary localization of the BBSome complex. |
| NPHP1 | Nephrocystin-1 | Together with BCAR1 it may play a role in the control of epithelial cell polarity. |
| BBS2 | BBSome complex member BBS2 | The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. |
| BBS4 | BBSome complex member BBS4 | The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. |
| BBS5 | BBSome complex member BBS5 | The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. |
Protein-family classification
Druggable: 1 · Difficult: 5 · Unknown: 12 · Druggable fraction: 0.06
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Scaffold/PPI | 5 | 4.8× | 0.009 |
| Other/Unknown | 12 | 1.2× | 0.371 |
| Protease | 1 | 2.0× | 0.393 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| CCDC28B | Other/Unknown | no | CCDC28 | |
| BBS1 | Other/Unknown | no | Quinoprotein_ADH-like_sf, BBS1, BBS1_N | |
| ARL6 | Other/Unknown | no | Small_GTP-bd, Small_GTPase_ARF/SAR, Small_GTPase_ARF | |
| BBS7 | Scaffold/PPI | no | WD40/YVTN_repeat-like_dom_sf, Bardet-Biedl_syndrome_7_prot, WD40_repeat_dom_sf | |
| PSMG2 | Other/Unknown | no | Proteasome_assmbl_chp_2_euk, Proteasome_assmbl_chaperone_2, PSMG2_sf | |
| CEP76 | Protease | yes | CEP76-C2, Papain-like_cys_pep_sf, CEP76 | |
| BBS10 | Other/Unknown | no | Cpn60/GroEL/TCP-1, GroEL-like_apical_dom_sf, TCP-1-like_intermed_sf | |
| BBS12 | Other/Unknown | no | Cpn60/GroEL/TCP-1, GroEL-like_apical_dom_sf, TCP-1-like_intermed_sf | |
| ZDHHC24 | Other/Unknown | no | Palmitoyltrfase_DHHC, PFA4/ZDH16/20/ERF2-like | |
| WDPCP | Scaffold/PPI | no | WD40/YVTN_repeat-like_dom_sf, Frtz, WD40_repeat_dom_sf | |
| BBIP1 | Other/Unknown | no | BBIP10 | |
| BBS9 | Other/Unknown | no | PTHB1, PHTB1_N_dom, PHTB1_GAE_dom | |
| IFT172 | Scaffold/PPI | no | WD40_rpt, TPR-like_helical_dom_sf, WD40/YVTN_repeat-like_dom_sf | |
| LZTFL1 | Other/Unknown | no | LZTFL1 | |
| NPHP1 | Scaffold/PPI | no | SH3_domain, NPHP1_SH3, SH3-like_dom_sf | |
| BBS2 | Scaffold/PPI | no | WD40/YVTN_repeat-like_dom_sf, Bardet-Biedl_syndrome_2_prot, BBS2_GAE_dom | |
| BBS4 | Other/Unknown | no | TPR-like_helical_dom_sf, TPR_rpt | |
| BBS5 | Other/Unknown | no | BBL5, PH-like_dom_sf, BBS5_PH |
Expression context
Cohort genes with no expression data: 0.
14 cohort genes are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 18 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| right uterine tube | 5 |
| sperm | 4 |
| bronchial epithelial cell | 4 |
| endothelial cell | 3 |
| calcaneal tendon | 3 |
| oocyte | 3 |
| secondary oocyte | 3 |
| primordial germ cell in gonad | 2 |
| olfactory segment of nasal mucosa | 2 |
| gastrocnemius | 1 |
| hindlimb stylopod muscle | 1 |
| muscle of leg | 1 |
| left ovary | 1 |
| ovary | 1 |
| Brodmann (1909) area 23 | 1 |
| oviduct epithelium | 1 |
| lateral nuclear group of thalamus | 1 |
| adult organism | 1 |
| gingival epithelium | 1 |
| ventricular zone | 1 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| CCDC28B | 243 | ubiquitous | marker | hindlimb stylopod muscle, gastrocnemius, muscle of leg |
| BBS1 | 134 | ubiquitous | yes | right uterine tube, left ovary, ovary |
| ARL6 | 228 | ubiquitous | marker | oviduct epithelium, Brodmann (1909) area 23, endothelial cell |
| BBS7 | 262 | ubiquitous | marker | endothelial cell, calcaneal tendon, lateral nuclear group of thalamus |
| PSMG2 | 288 | ubiquitous | marker | primordial germ cell in gonad, adult organism, gingival epithelium |
| CEP76 | 247 | ubiquitous | yes | secondary oocyte, oocyte, sperm |
| BBS10 | 253 | ubiquitous | yes | calcaneal tendon, endothelial cell, ventricular zone |
| BBS12 | 204 | ubiquitous | yes | primordial germ cell in gonad, sperm, bronchial epithelial cell |
| ZDHHC24 | 232 | ubiquitous | marker | parotid gland, diaphragm, triceps brachii |
| WDPCP | 253 | ubiquitous | marker | pancreatic ductal cell, kidney epithelium, mucosa of paranasal sinus |
| BBIP1 | 288 | ubiquitous | marker | epithelium of nasopharynx, buccal mucosa cell, sperm |
| BBS9 | 279 | ubiquitous | marker | oocyte, secondary oocyte, calcaneal tendon |
| IFT172 | 236 | ubiquitous | marker | right uterine tube, bronchial epithelial cell, left testis |
| LZTFL1 | 282 | ubiquitous | marker | bronchial epithelial cell, sperm, epithelium of bronchus |
| NPHP1 | 193 | ubiquitous | marker | right uterine tube, bronchial epithelial cell, olfactory segment of nasal mucosa |
| BBS2 | 262 | ubiquitous | marker | adrenal tissue, right adrenal gland cortex, peripheral nervous system |
| BBS4 | 278 | ubiquitous | marker | right uterine tube, oocyte, secondary oocyte |
| BBS5 | 140 | ubiquitous | marker | right uterine tube, male germ line stem cell (sensu Vertebrata) in testis, olfactory segment of nasal mucosa |
Protein interactions among cohort
Intra-cohort edges: 63.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| BBS10 | 3,224 |
| BBS4 | 2,544 |
| NPHP1 | 2,302 |
| BBS1 | 2,189 |
| IFT172 | 1,922 |
| BBS2 | 1,824 |
| ARL6 | 1,811 |
| CEP76 | 1,759 |
| BBS7 | 1,622 |
| LZTFL1 | 1,428 |
Intra-cohort edges
| A | B | Sources |
|---|---|---|
| ARL6 | BBIP1 | intact |
| ARL6 | BBS1 | intact, string_interaction |
| ARL6 | BBS10 | string_interaction |
| ARL6 | BBS12 | string_interaction |
| ARL6 | BBS2 | string_interaction |
| ARL6 | BBS4 | intact |
| ARL6 | BBS5 | string_interaction |
| ARL6 | BBS7 | intact, string_interaction |
| ARL6 | BBS9 | intact |
| ARL6 | WDPCP | string_interaction |
| BBIP1 | BBS4 | intact |
| BBIP1 | BBS5 | biogrid_interaction, intact |
| BBIP1 | BBS7 | intact |
| BBS1 | BBS10 | string_interaction |
| BBS1 | BBS12 | intact, string_interaction |
| BBS1 | BBS2 | biogrid_interaction, intact, string_interaction |
| BBS1 | BBS4 | biogrid_interaction, intact, string_interaction |
| BBS1 | BBS5 | biogrid_interaction, intact, string_interaction |
| BBS1 | BBS7 | biogrid_interaction, intact, string_interaction |
| BBS1 | BBS9 | biogrid_interaction, intact |
| BBS1 | CCDC28B | intact, string_interaction |
| BBS1 | LZTFL1 | biogrid_interaction, intact, string_interaction |
| BBS1 | WDPCP | string_interaction |
| BBS10 | BBS12 | intact, string_interaction |
| BBS10 | BBS2 | string_interaction |
| BBS10 | BBS4 | string_interaction |
| BBS10 | BBS5 | string_interaction |
| BBS10 | BBS7 | biogrid_interaction, intact, string_interaction |
| BBS10 | BBS9 | intact |
| BBS10 | CCDC28B | string_interaction |
| BBS10 | LZTFL1 | string_interaction |
| BBS10 | WDPCP | string_interaction |
| BBS12 | BBS2 | intact, string_interaction |
| BBS12 | BBS4 | intact, string_interaction |
| BBS12 | BBS5 | string_interaction |
| BBS12 | BBS7 | biogrid_interaction, intact, string_interaction |
| BBS12 | BBS9 | intact |
| BBS12 | CCDC28B | string_interaction |
| BBS12 | LZTFL1 | string_interaction |
| BBS12 | WDPCP | string_interaction |
| BBS2 | BBS4 | biogrid_interaction, intact, string_interaction |
| BBS2 | BBS5 | biogrid_interaction, intact, string_interaction |
| BBS2 | BBS7 | biogrid_interaction, intact, string_interaction |
| BBS2 | BBS9 | biogrid_interaction, intact |
| BBS2 | CCDC28B | intact, string_interaction |
| BBS2 | LZTFL1 | biogrid_interaction, string_interaction |
| BBS2 | WDPCP | string_interaction |
| BBS4 | BBS5 | biogrid_interaction, intact, string_interaction |
| BBS4 | BBS7 | biogrid_interaction, intact, string_interaction |
| BBS4 | BBS9 | biogrid_interaction, intact |
Structural data
PDB: 10 · AlphaFold-only: 8 · No structure: 0
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| PSMG2 | Q969U7 | 13 |
| BBS9 | Q3SYG4 | 2 |
| NPHP1 | O15259 | 2 |
| BBS1 | Q8NFJ9 | 1 |
| ARL6 | Q9H0F7 | 1 |
| WDPCP | O95876 | 1 |
| BBIP1 | A8MTZ0 | 1 |
| IFT172 | Q9UG01 | 1 |
| BBS4 | Q96RK4 | 1 |
| BBS5 | Q8N3I7 | 1 |
AlphaFold-only cohort genes (top 30 by pLDDT)
| Symbol | UniProt | pLDDT |
|---|---|---|
| BBS7 | Q8IWZ6 | 92.99 |
| ZDHHC24 | Q6UX98 | 89.76 |
| BBS2 | Q9BXC9 | 89.49 |
| CEP76 | Q8TAP6 | 87.18 |
| LZTFL1 | Q9NQ48 | 83.74 |
| BBS12 | Q6ZW61 | 73.92 |
| BBS10 | Q8TAM1 | 71.26 |
| CCDC28B | Q9BUN5 | 71.15 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 21. Enrichment computed across 18 evidence-associated genes (15 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 15 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| BBSome-mediated cargo-targeting to cilium | 11 | 364.1× | 4e-27 | BBS1, ARL6, BBS7, BBS10, BBS12, BBIP1, BBS9, LZTFL1 (+3 more) |
| Cargo trafficking to the periciliary membrane | 10 | 165.5× | 1e-20 | BBS1, ARL6, BBS7, BBS10, BBS12, BBIP1, LZTFL1, BBS2 (+2 more) |
| Cilium Assembly | 11 | 79.8× | 2e-19 | BBS1, ARL6, BBS7, CEP76, BBS10, BBS12, BBIP1, LZTFL1 (+3 more) |
| Organelle biogenesis and maintenance | 11 | 48.4× | 5e-17 | BBS1, ARL6, BBS7, CEP76, BBS10, BBS12, BBIP1, LZTFL1 (+3 more) |
| Anchoring of the basal body to the plasma membrane | 2 | 15.1× | 0.032 | CEP76, NPHP1 |
| Centrosome maturation | 1 | 16.9× | 0.147 | CEP76 |
| Proteasome assembly | 1 | 13.6× | 0.147 | PSMG2 |
| Intraflagellar transport | 1 | 13.4× | 0.147 | IFT172 |
| Hedgehog ‘off’ state | 1 | 11.9× | 0.147 | IFT172 |
| Loss of Nlp from mitotic centrosomes | 1 | 10.6× | 0.147 | CEP76 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 1 | 10.6× | 0.147 | CEP76 |
| AURKA Activation by TPX2 | 1 | 10.2× | 0.147 | CEP76 |
| Recruitment of mitotic centrosome proteins and complexes | 1 | 9.1× | 0.147 | CEP76 |
| Regulation of PLK1 Activity at G2/M Transition | 1 | 8.5× | 0.147 | CEP76 |
| Mitotic G2-G2/M phases | 1 | 8.5× | 0.147 | CEP76 |
| G2/M Transition | 1 | 8.5× | 0.147 | CEP76 |
| Recruitment of NuMA to mitotic centrosomes | 1 | 7.8× | 0.150 | CEP76 |
| Mitotic Prometaphase | 1 | 4.6× | 0.226 | CEP76 |
| M Phase | 1 | 4.4× | 0.226 | CEP76 |
| Cell Cycle, Mitotic | 1 | 3.2× | 0.284 | CEP76 |
| Cell Cycle | 1 | 2.4× | 0.345 | CEP76 |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 18 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| cilium assembly | 11 | 45.0× | 1e-14 | CCDC28B, BBS1, ARL6, BBS7, WDPCP, BBIP1, BBS9, IFT172 (+3 more) |
| fat cell differentiation | 7 | 70.5× | 3e-10 | BBS1, ARL6, BBS7, BBS12, BBS9, BBS2, BBS4 |
| melanosome transport | 5 | 212.8× | 7e-10 | ARL6, BBS7, BBS2, BBS4, BBS5 |
| non-motile cilium assembly | 6 | 96.8× | 7e-10 | BBS1, BBS7, BBS10, IFT172, BBS2, BBS4 |
| visual perception | 8 | 35.3× | 7e-10 | BBS1, ARL6, BBS7, BBS10, BBS9, BBS2, BBS4, BBS5 |
| photoreceptor cell maintenance | 5 | 99.6× | 3e-08 | BBS1, BBS10, BBS12, BBS2, BBS4 |
| regulation of cilium beat frequency involved in ciliary motility | 3 | 312.1× | 2e-06 | BBS1, BBS2, BBS4 |
| protein localization to cilium | 4 | 89.2× | 2e-06 | BBS1, ARL6, BBS9, BBS4 |
| striatum development | 3 | 187.2× | 8e-06 | BBS1, BBS2, BBS4 |
| heart looping | 4 | 59.4× | 8e-06 | BBS7, IFT172, BBS4, BBS5 |
| brain morphogenesis | 3 | 122.1× | 2e-05 | BBS1, BBS2, BBS4 |
| chaperone-mediated protein complex assembly | 3 | 117.0× | 3e-05 | PSMG2, BBS10, BBS12 |
| intraciliary transport | 3 | 93.6× | 5e-05 | BBS12, WDPCP, IFT172 |
| negative regulation of appetite by leptin-mediated signaling pathway | 2 | 468.1× | 7e-05 | BBS2, BBS4 |
| adult behavior | 3 | 78.0× | 7e-05 | BBS1, BBS2, BBS4 |
| protein transport | 5 | 12.2× | 4e-04 | BBS7, BBIP1, BBS9, BBS4, BBS5 |
| hippocampus development | 3 | 38.5× | 5e-04 | BBS1, BBS2, BBS4 |
| erythrocyte homeostasis | 2 | 144.0× | 7e-04 | BBIP1, BBS4 |
| cerebral cortex development | 3 | 34.2× | 7e-04 | BBS1, BBS2, BBS4 |
| smoothened signaling pathway | 3 | 30.2× | 1e-03 | BBS7, WDPCP, IFT172 |
| ventricular system development | 2 | 93.6× | 0.001 | BBS1, BBS4 |
| eating behavior | 2 | 66.9× | 0.003 | BBS12, BBIP1 |
| B cell homeostasis | 2 | 62.4× | 0.003 | BBIP1, BBS4 |
| Golgi to plasma membrane protein transport | 2 | 58.5× | 0.003 | BBS1, BBS2 |
| positive regulation of multicellular organism growth | 2 | 55.1× | 0.004 | BBS2, BBS4 |
| intracellular protein localization | 3 | 17.4× | 0.004 | BBS7, BBS10, BBS2 |
| Wnt signaling pathway | 3 | 16.6× | 0.004 | ARL6, BBIP1, BBS4 |
| limb development | 2 | 45.7× | 0.005 | BBS7, IFT172 |
| dendrite development | 2 | 43.5× | 0.005 | BBS1, BBS4 |
| hindgut development | 1 | 936.2× | 0.005 | IFT172 |
Therapeutics
Drug target analysis
Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 18
Druggability breadth: 1 of 18 evidence-associated genes (6%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| CCDC28B | 0 | 0 |
| BBS1 | 0 | 0 |
| ARL6 | 0 | 0 |
| BBS7 | 0 | 0 |
| PSMG2 | 0 | 0 |
| CEP76 | 0 | 0 |
| BBS10 | 0 | 0 |
| BBS12 | 0 | 0 |
| ZDHHC24 | 0 | 0 |
| WDPCP | 0 | 0 |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 0.
Cohort genes with ChEMBL bioactivity (full, sorted by assay count)
| Symbol | Assays | Type breakdown |
|---|---|---|
| PSMG2 | 5 | Binding:5 |
Pharmacogenomics
Cohort genes with a PharmGKB record: 18; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 0 | |
| B | Phased (≥1) drug, not yet approved | 0 | |
| C | Druggable family + PDB, no drug | 0 | |
| D | Druggable family + AlphaFold only, no drug | 1 | CEP76 |
| E | Difficult family or no structure, no drug | 17 | CCDC28B, BBS1, ARL6, BBS7, PSMG2, BBS10, BBS12, ZDHHC24, WDPCP, BBIP1 (+7 more) |
Undrugged target profiles
18 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| CCDC28B | 0 | — |
| BBS1 | 0 | — |
| ARL6 | 0 | — |
| BBS7 | 0 | — |
| PSMG2 | 5 | — |
| CEP76 | 0 | — |
| BBS10 | 0 | — |
| BBS12 | 0 | — |
| ZDHHC24 | 0 | — |
| WDPCP | 0 | — |
| BBIP1 | 0 | — |
| BBS9 | 0 | — |
| IFT172 | 0 | — |
| LZTFL1 | 0 | — |
| NPHP1 | 0 | — |
| BBS2 | 0 | — |
| BBS4 | 0 | — |
| BBS5 | 0 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 1.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| EARLY_PHASE1 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT07269665 | EARLY_PHASE1 | NOT_YET_RECRUITING | First-in-Human, Dose Escalation Trial of AXV-101 in BBS1-Related Retinal Degeneration |